Found 0 matching trials
Pharmacological Modulation of Cocaine Effects - 1
PHASE2The purpose of this study is to conduct human laboratory studies of possibl...
Location
Johns Hopkins University (BPRU) Bayview Campus
Safety and Effectiveness of the Selegiline "Patch" for Decreased Mental Function in HIV Patients
PHASE2A decrease in mental function often occurs in patients with HIV. Antiretrov...
Location
UCLA CARE Center CRS
Testing a Full Substitution Therapy Approach As Treatment of Tobacco Dependence
NAThis study will test a new medication strategy designed to help smokers qui...
Location
Centre for Addiction and Mental Health
Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1
PHASE3The purpose of this study is to evaluate the Selegiline Transdermal System ...
Location
Tucson VA Medical Center
Combined Donepezil and Selegiline Effects on Cocaine-Reinforced Behavior
PHASE2No medications are currently available for treatment of psychostimulant add...
Location
Kansas City VA Medical Center
Safety, Tolerability and Efficacy of the Transdermal System in Elderly Subjects With Major Depression
PHASE3Objective of this 16-week, open-label study is to assess the safety and tol...
Location
Mohammed Bari, M.D.
Effectiveness of Selegiline in Treating Marijuana Dependent Individuals - 1
PHASE2During the past 15 years, the demand for treatment for marijuana-related pr...
Phase IV:Safety and Efficacy of EMSAM in Adolescents With Major Depression
PHASE4The primary purpose of your participation in this study is to help answer t...
Location
Dr. Nelson Handal
Selegiline for the Treatment of Excessive Daytime Sleepiness in Parkinson's Disease
PHASE4This is a multi-center, open-label, single-arm 8-week investigation of Sele...
Location
Changshu Hospital Affiliated to Nanjing University of Chinese Medicine
Clinical Trial of Selegiline Plus Docetaxel for the Treatment of Metastatic, Castrate-resistant Prostate Adenocarcinoma
PHASE2The objective of this clinical study is to evaluate the effectiveness and s...
Location
University of Pécs, Clinical Centre, Department of Oncotherapy